AML stem cells, defined as CD34+/ROSlow, have been shown to have elevated autophagy compared to CD34+/ROShigh cells, and inhibition of autophagy in AML stem cells resulted in decreased engraftment in mice [19]. This evidence concerns the gene CD34 and acute myeloid leukemia.